← Back to patent-cliff list
Secretin
Tier C — Watch / tradeSecretin
Chirhoclin Inc
Originator
2004
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Secretin receptor
Brand：ChiRhoStim, SecreFlo
Indications (approved)：胰腺疾病, Contrast imaging, Diagnostic agent
Regional status
US
Approved
2004-04-09
EU
No progress
2016-08-02
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Secretin?
Approved indications include: 胰腺疾病, Contrast imaging, Diagnostic agent.
When does the Secretin patent expire?
No public expiry year is available for Secretin yet; this page updates once verified.
How do I get a quote for Secretin intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27